{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:31:07Z","timestamp":1773289867438,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":364,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2018]]},"DOI":"10.6061\/clinics\/2018\/e184","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T20:05:03Z","timestamp":1532635503000},"page":"e184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer"],"prefix":"10.1016","volume":"73","author":[{"given":"Marcia M.","family":"Marques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriane F.","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taciane","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 Aloisio da Costa","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristovam","family":"Scapulatempo-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 L.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael Dale Cotrim Guerreiro da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.6061\/clinics\/2018\/e184_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.6061\/clinics\/2018\/e184_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in Cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu Rev Med"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e184_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2011.03.009","article-title":"MicroRNA history: discovery, recent applications, and next frontiers","volume":"717","author":"Almeida","year":"2011","journal-title":"Mutat Res"},{"issue":"3","key":"10.6061\/clinics\/2018\/e184_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S1415-47572011000300001","article-title":"Mechanisms and role of microRNA deregulation in cancer onset and progression","volume":"34","author":"Palmero","year":"2011","journal-title":"Genet Mol Biol"},{"issue":"9","key":"10.6061\/clinics\/2018\/e184_bib5","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.6061\/clinics\/2018\/e184_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev Biol"},{"issue":"10","key":"10.6061\/clinics\/2018\/e184_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol"},{"issue":"12","key":"10.6061\/clinics\/2018\/e184_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1051\/medsci\/200824121049","article-title":"[Oncogenic and tumour suppressor microRNAs]","volume":"24","author":"Finoux","year":"2008","journal-title":"Med Sci (Paris)"},{"issue":"4","key":"10.6061\/clinics\/2018\/e184_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10555-010-9257-9","article-title":"The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network","volume":"29","author":"Boominathan","year":"2010","journal-title":"Cancer Metastasis Rev"},{"issue":"52","key":"10.6061\/clinics\/2018\/e184_bib10","doi-asserted-by":"crossref","first-page":"21075","DOI":"10.1073\/pnas.1118922109","article-title":"Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs","volume":"108","author":"Frost","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.6061\/clinics\/2018\/e184_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tips.2007.10.014","article-title":"Targeting microRNA expression to regulate angiogenesis","volume":"29","author":"Kuehbacher","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.6061\/clinics\/2018\/e184_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/wrna.1112","article-title":"A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA","volume":"3","author":"Huang","year":"2012","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"4","key":"10.6061\/clinics\/2018\/e184_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/emboj.2008.294","article-title":"Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7","volume":"28","author":"Dangi-Garimella","year":"2009","journal-title":"EMBO J"},{"issue":"9","key":"10.6061\/clinics\/2018\/e184_bib14","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1172\/JCI45390","article-title":"miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"10.6061\/clinics\/2018\/e184_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmb.2010.07.051","article-title":"The miR-15\/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases","volume":"402","author":"Finnerty","year":"2010","journal-title":"J Mol Biol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e184_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/hep.26378","article-title":"Genome-wide screening reveals that miR-195 targets the TNF-\u03b1\/NF-\u03baB pathway by down-regulating I\u03baB kinase alpha and TAB3 in hepatocellular carcinoma","volume":"58","author":"Ding","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.6061\/clinics\/2018\/e184_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/modpathol.2008.135","article-title":"Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma","volume":"22","author":"Flavin","year":"2009","journal-title":"Mod Pathol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e184_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.gene.2012.12.103","article-title":"MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer","volume":"518","author":"Deng","year":"2013","journal-title":"Gene"},{"issue":"3","key":"10.6061\/clinics\/2018\/e184_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060155","article-title":"The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma","volume":"8","author":"Furuta","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.6061\/clinics\/2018\/e184_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.22919","article-title":"MicroRNA-195 suppresses tumorigenicity and regulates G1\/S transition of human hepatocellular carcinoma cells","volume":"50","author":"Xu","year":"2009","journal-title":"Hepatology"},{"issue":"26","key":"10.6061\/clinics\/2018\/e184_bib21","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/onc.2012.324","article-title":"Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma","volume":"32","author":"Bhattacharya","year":"2013","journal-title":"Oncogene"},{"issue":"4","key":"10.6061\/clinics\/2018\/e184_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/ERC-13-0098","article-title":"Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma","volume":"20","author":"Caramuta","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.6061\/clinics\/2018\/e184_bib23","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-10-1800","article-title":"Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer","volume":"17","author":"Li","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.6061\/clinics\/2018\/e184_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1634\/theoncologist.2010-0103","article-title":"Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease","volume":"15","author":"Heneghan","year":"2010","journal-title":"Oncologist"},{"issue":"3","key":"10.6061\/clinics\/2018\/e184_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","article-title":"Circulating microRNAs as novel minimally invasive biomarkers for breast cancer","volume":"251","author":"Heneghan","year":"2010","journal-title":"Ann Surg"},{"issue":"11","key":"10.6061\/clinics\/2018\/e184_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050459","article-title":"Relationship between circulating and tissue microRNAs in a murine model of breast cancer","volume":"7","author":"Waters","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.6061\/clinics\/2018\/e184_bib27","first-page":"103","article-title":"Tumor cell-derived exosomes: a message in a bottle","volume":"1826","author":"Kharaziha","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.6061\/clinics\/2018\/e184_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737140.9.1.51","article-title":"The NSABP Study of Tamoxifen and Raloxifene (STAR) trial","volume":"9","author":"Vogel","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.6061\/clinics\/2018\/e184_bib29","series-title":"AJCC Cancer Staging Manual","first-page":"345","article-title":"Breast","author":"Edge","year":"2010"},{"issue":"8","key":"10.6061\/clinics\/2018\/e184_bib30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast Cancer","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol"},{"key":"10.6061\/clinics\/2018\/e184_bib31","author":"R: The R Project for Statistical Computing"},{"issue":"9","key":"10.6061\/clinics\/2018\/e184_bib32","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.6061\/clinics\/2018\/e184_bib33","author":"ROCR"},{"issue":"1","key":"10.6061\/clinics\/2018\/e184_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/ncrna1010053","article-title":"Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer","volume":"1","author":"Bullock","year":"2015","journal-title":"Non-Coding RNA"},{"issue":"1","key":"10.6061\/clinics\/2018\/e184_bib35","first-page":"24","article-title":"Regulation of cancer metastasis by cell-free miRNAs","volume":"1855","author":"Ale\u010dkovi\u0107","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"10.6061\/clinics\/2018\/e184_bib36","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1158\/0008-5472.CAN-07-5019","article-title":"Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer","volume":"67","author":"Sempere","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"10.6061\/clinics\/2018\/e184_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056634","article-title":"Prognostic implications of MicoRNA miR-195 expression in human tongue squamous cell carcinoma","volume":"8","author":"Jia","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.6061\/clinics\/2018\/e184_bib38","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1349-7006.2011.02092.x","article-title":"MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients","volume":"102","author":"Lakomy","year":"2011","journal-title":"Cancer Sci"},{"issue":"2","key":"10.6061\/clinics\/2018\/e184_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/hep.26373","article-title":"MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.6061\/clinics\/2018\/e184_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041574","article-title":"Micro-RNA-195 and -451 regulate the LKB1\/AMPK signaling axis by targeting MO25","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"issue":"31","key":"10.6061\/clinics\/2018\/e184_bib41","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3748\/wjg.v17.i31.3645","article-title":"Potentially predictive microRNAs of gastric cancer with metastasis to lymph node","volume":"17","author":"Wu","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.6061\/clinics\/2018\/e184_bib42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/clinchem\/48.8.1151","article-title":"Practice guidelines for tumor marker use in the clinic","volume":"48","author":"Sturgeon","year":"2002","journal-title":"Clin Chem"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222005270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222005270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:50:56Z","timestamp":1761720656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222005270"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322018000100240&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/expression-of-tumor-suppressors-mir-195-and-let-7a-as-potential-biomarkers-of-invasive-breast-cancer\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":42,"alternative-id":["S1807593222005270"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e184","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e184"}}